| 发明名称 |
ANTI-TNF AND ANTI-IL17 COMBINATION THERAPY BIOMARKERS FOR INFLAMMATORY DISEASE |
| 摘要 |
The invention provides methods for predicting the efficacy of anti-TNF and anti- IL17 combination therapies in the treatment of a subject suffering from inflammatory disease by determining the level CXCL1 and/or CXCL5 markers in a sample derived from the subject. |
| 申请公布号 |
CA2897997(A1) |
申请公布日期 |
2014.07.24 |
| 申请号 |
CA20142897997 |
申请日期 |
2014.01.21 |
| 申请人 |
ABBVIE INC. |
发明人 |
VOSS, JEFFREY W.;CUFF, CAROLYN A. |
| 分类号 |
G01N33/68;G01N33/50 |
主分类号 |
G01N33/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
